Nuzenio

Pelitecan

Pelitecan news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Timeline

Wed, 05 Aug 2026 16:09:36 GMTFDA Names Zocilurtatug Pelitecan Orphan Drug in Neuroendocrine Carcinomas - Targeted Oncology
Tue, 04 Aug 2026 12:20:33 GMTFDA grants orphan drug designation to Zai Lab's zoci for neuroendocrine carcinomas - AllSci
Mon, 03 Aug 2026 15:59:22 GMTFDA Grants Orphan Drug Designation to Zocilurtatug Pelitecan for Neuroendocrine Carcinomas - OncLive
Mon, 03 Aug 2026 12:21:26 GMTZai Lab says FDA grants Orphan Drug Designation for zocilurtatug pelitecan - TipRanks
Mon, 03 Aug 2026 11:00:00 GMTU.S. FDA Grants Orphan Drug Designation to Zai Lab’s DLL3-Targeting ADC Zocilurtatug Pelitecan (Zoci) for the Treatment of Neuroendocrine Carcinomas (NECs) - Business Wire

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Pelitecan.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.